What is SomnoMed Limited (SOMNF)?

SomnoMed Limited (SOMNF) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of SOMNF?

The current price of SOMNF is $0.18. Prices are updated in real time on Stocks360.

What is SOMNF's price-to-earnings (PE) ratio?

SOMNF's trailing twelve-month PE ratio is -23.97, based on current price and earnings per share data available on Stocks360.

What is SOMNF's market capitalization?

SOMNF's market capitalization is $39,558,242.00, placing it in the small-cap tier.

SomnoMed Limited (SOMNF)

Stock analysis · OTC · Healthcare · Medical - Devices

$0.18

Market Cap

$39.56M

PE (TTM)

-23.97

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.80

Day Range

$0.18 – $0.18

52-wk Range

$0.16 – $0.51

Avg Volume

N/A

Volume

0.00

SomnoMed Limited (SOMNF) is a publicly traded company in the Healthcare sector. Latest price: $0.18. Market cap $39.56M. Trailing PE -23.97. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-31 · $0.46 2026-10-28 · $0.18 (-60.87%)

Earnings

Most Recent

Aug 27, 2026

EPS $-0.01 vs est. $0.00

Missed by $0.01

Next Earnings

Feb 26, 2027

EPS estimate $0.01

Proprietary Signals

Signal snapshot temporarily unavailable.

About SomnoMed Limited

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-23.97×
P/S (TTM)	0.56×
P/B	1.34×
P/FCF (TTM)	12.70×
EV / EBITDA	8.05×
EV / Sales	0.45×
Earnings Yield	-4.17%
Free Cash Flow Yield	7.87%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$52.01M
Revenue (TTM)	$114.53M
Net Income (TTM)	-$2.66M
Free Cash Flow (TTM)	$5.23M
Net Debt	-$11.73M
Working Capital	$15.68M
Gross Margin	54.48%
Operating Margin	0.85%
Net Margin	-2.31%
Return on Equity	-5.44%
Return on Invested Capital	1.81%